Perrigo Company plc (NYSE:PRGO – Get Free Report) declared a quarterly dividend on Wednesday, February 19th, RTT News reports. Stockholders of record on Friday, March 7th will be given a dividend of 0.29 per share on Tuesday, March 25th. This represents a $1.16 annualized dividend and a dividend yield of 4.00%. The ex-dividend date of this dividend is Friday, March 7th. This is a positive change from Perrigo’s previous quarterly dividend of $0.28.
Perrigo has increased its dividend by an average of 4.8% per year over the last three years and has increased its dividend every year for the last 23 years. Perrigo has a dividend payout ratio of 34.6% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Perrigo to earn $3.06 per share next year, which means the company should continue to be able to cover its $1.16 annual dividend with an expected future payout ratio of 37.9%.
Perrigo Stock Performance
NYSE PRGO opened at $29.01 on Wednesday. The stock has a fifty day simple moving average of $25.08 and a 200 day simple moving average of $26.21. Perrigo has a twelve month low of $23.14 and a twelve month high of $33.46. The company has a market capitalization of $3.96 billion, a price-to-earnings ratio of -24.79 and a beta of 0.48. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94.
Insiders Place Their Bets
In related news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $28.27, for a total transaction of $497,495.46. Following the completion of the transaction, the director now owns 5,409 shares in the company, valued at approximately $152,912.43. This represents a 76.49 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.40% of the company’s stock.
Analysts Set New Price Targets
PRGO has been the subject of several research analyst reports. Argus lowered Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Piper Sandler lowered Perrigo from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $34.00 to $27.00 in a report on Monday, January 6th. Finally, StockNews.com downgraded Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Perrigo has an average rating of “Hold” and a consensus target price of $33.00.
Get Our Latest Research Report on Perrigo
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Stories
- Five stocks we like better than Perrigo
- Most active stocks: Dollar volume vs share volume
- Lemonade’s Q4 Surge: Has This AI-Powered Insurer Turned a Corner?
- What is the FTSE 100 index?
- 2 Energy Stocks to Play Both Sides of Tariff Uncertainty
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Raytheon vs. Lockheed Martin: Which Stock Has More Upside?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.